Furthermore, sphere-forming assays demonstrated that siRNA-mediated reduction in RPS6 expression significantly suppressed the sphere forming potential of glioblastoma cells and strongly reduced the expression of glioblastoma stem cell markers. The gene discussed is RPS6; the disease is glioblastoma.